MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    The contribution of striatal dopamine to feedforward motor control during gait initiation in Parkinson’s disease

    G. Brandt, C. Palmisano, J. Brumberg, N. Pozzi, A. Canessa, G. Pezzoli, I. Isaias, J. Volkmann (Würzburg, Germany)

    Objective: To establish the contribution of striatal dopamine to gait initiation in Parkinson’s disease. Background: Gait initiation (GI) is characterized by anticipatory postural adjustments (APAs),…
  • 2019 International Congress

    Skin could be the new peripheral tissue of interest in Parkinson’s disease transcriptomics

    A. Planken, P. Taba, S. Kõks, KM. Kasterpalu, L. Kadastik-Eerme, F. Lättekivi, L. Kurvits, E. Reimann (Tartu, Estonia)

    Objective: Profiling gene expression changes in peripheral tissues in PD. Background: Obtaining tissue for gene expression analysis in PD from CNS is done post mortem.…
  • 2019 International Congress

    Experimental model of developing of Parkinson’s disease

    M. Tukhtamishev, F. Akhmedova (Tashkent, Uzbekistan)

    Objective: Analyzing the reserpine model of Parkinsonian syndrome Background: There are several experimental models of Parkinson's disease: reserpine, methamphetamine, 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - substances that…
  • 2019 International Congress

    Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson’s disease

    F. Hopfner, M. Wod, G. Höglinger, M. Blaabjerg, T. Roesler, G. Kuhlenbäumer, K. Christensen, G. Deuschl, A. Pottegård (Kiel, Germany)

    Objective: Verification of the previously reported association between chronic use of β2-adrenoreceptor (β2AR) agonist and antagonist with reduced and increased risk of Parkinson’s disease (PD),…
  • 2019 International Congress

    Sick leaves in the years preceding the diagnosis of Parkinson’s disease: a nationwide case-control study in France

    F. Moisan, L. Mandereau-Bruno, E. Moutengou, L. Carcaillon-Bentata, A. Elbaz (Saint-Maurice, France)

    Objective: To examine whether the frequency of sick leaves is higher in patients with Parkinson’s disease (PD) than in controls in the years preceding diagnosis.…
  • 2019 International Congress

    Wilson’s disease in Finland

    J. Sipilä, M. Hietala, V. Kaasinen (Joensuu, Finland)

    Objective: To investigate the epidemiology and clinical picture of Wilson’s disease (WD) in Finland Background: There are few robust studies on WD epidemiology and none…
  • 2019 International Congress

    Gray Matter Abnormalities in Parkinson’s disease: a Voxel-wise meta-analysis

    XR. Xu, Q. Han, JY. Lin, L. Wang, HF. Shang (Chengdu, China)

    Objective: To summarize the consistent GM volume changes in PD patients from whole brain VBM studies. Background: Grey matter (GM) anomaly in Parkinson’s disease (PD)…
  • 2019 International Congress

    Unscheduled disruption of Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD)

    A. Blain, O. Lagha-Boukbiza, O. Gebus, M. Anheim, C. Tranchant (Strasbourg, France)

    Objective: This is a descriptive study about consequences and management of unscheduled DBS disruption in 12 PD patients. Background: Unscheduled DBS disruption may  occur mainly…
  • 2019 International Congress

    Deep brain stimulation of Caudal Zona incerta: Case series

    DR. Ginjupally, Z. Guduru, T. Hines Iii, T. Ali, G. Quintero, C. van Horne (Lexington, KY, USA)

    Objective: With the advancement of deep brain stimulation (DBS) techniques, a renewed interest in the posterior sub thalamic area (PSA) for the treatment of Parkinson's…
  • 2019 International Congress

    Stimulation of the Left Anterior Sensorimotor Subthalamic Nucleus Improves Voice Function in Parkinson’s Disease

    A. Jorge, C. Dastolfo-Hromack, W. Lipski, I. Kratter, L. Smith, J. Gartner-Schmidt, R. Richardson (Pittsburgh, PA, USA)

    Objective: Determine the relationship of active contact location to postoperative changes in cepstral analyses of voice, following subthalamic nucleus (STN) deep brain stimulation (DBS) for…
  • « Previous Page
  • 1
  • …
  • 172
  • 173
  • 174
  • 175
  • 176
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley